401 filings
Page 6 of 21
8-K
wcifho78
25 Oct 07
Imclone Systems Reports Third Quarter 2007 Financial Results
12:00am
8-K
0x1154w4
18 Oct 07
Imclone and Bristol-myers Squibb Announce Joint Agreement
12:00am
S-8
0a6vi
9 Oct 07
Registration of securities for employees
12:00am
8-K
cookna ivss4ulj
4 Oct 07
Other Events
12:00am
8-K
ecp3i6
28 Sep 07
Departure of Directors or Principal Officers
12:00am
CORRESP
zyth1vgqjtllx512i5s7
21 Sep 07
Correspondence with SEC
12:00am
8-K
pl0x2lpnqx4
11 Sep 07
Other Events
12:00am
8-K
zrx8zyxc
10 Sep 07
Other Events
12:00am
8-K
fdw8b
29 Aug 07
Departure of Directors or Principal Officers
12:00am
8-K
hgaim8tet4ij
24 Aug 07
Fda Approves Imclone Systems’ New State-of-the-art Manufacturing Facility
12:00am
8-K
zh8xfoxm0f wdnb
23 Aug 07
Departure of Directors or Principal Officers
12:00am
8-K
rnxt6cojfvs gp
10 Aug 07
Imclone Systems Appoints John H. Johnson Chief Executive Officer
12:00am
8-K
sytpb0wfx5vp7 db661
31 Jul 07
Imclone Systems Reports Second Quarter 2007 Financial Results
12:00am
8-K
t3tjqetq
30 Jul 07
Bristol-myers Squibb and Imclone Systems Significantly Expand Erbitux Clinical Development Program
12:00am
8-K
zjcm299e5rti gzki2z
13 Jul 07
Other Events
12:00am
8-K
wzk4s5792r04h7
10 Jul 07
Departure of Directors or Principal Officers
12:00am
8-K
yms646 vd7g7bc9
8 Jun 07
Extensive Clinical Data on Erbitux® Presented at the 2007 Asco Annual Meeting
12:00am